See analyst estimates and all valuation multiples for BioTech
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $772B | 13.1x | 30.5x | |
| $478B | 5.1x | 13.6x | |
| $466B | 7.8x | 18.2x | |
| $263B | 4.7x | 11.6x | |
| $244B | 3.8x | 8.3x | |
| $243B | 5.5x | 21.9x | |
| $205B | 5.8x | 11.3x | |
| $187B | 3.0x | 7.5x | |
| $169B | 6.9x | 22.1x | |
| $166B | 5.8x | 11.0x | |
| $124B | 2.6x | 7.7x | |
| $107B | 2.5x | 7.4x | |
| $103B | 8.7x | 22.5x | |
| $72.1B | 2.4x | 9.0x | |
| $69.8B | 7.4x | 17.0x | |
| $69.6B | 1.3x | 6.2x | |
| $69.3B | 8.5x | 16.7x | |
| $67.1B | 2.7x | 9.5x | |
| $65.4B | 4.2x | 12.4x | |
| $63.6B | 4.5x | 12.9x | |
| $60.8B | 18.3x | 126.5x | |
| $54.2B | 6.6x | 22.5x | |
| $53.8B | 11.8x | 39.8x | |
| $26.4B | 7.7x | 25.6x | |
| $25.8B | 1.8x | 6.2x | |
| $25.8B | 2.4x | 12.0x | |
| $25.2B | 12.4x | -95.3x | |
| $23.2B | 1.8x | 8.5x | |
| $23.1B | 9.1x | 38.5x | |
| $22.7B | 11.3x | 30.4x | |
| $22.3B | 7.6x | 8.0x | |
| $20.0B | 51.4x | 450.5x | |
| $17.8B | 10.2x | 80.5x | |
| $10.9B | 5.3x | 14.3x | |
| $10.9B | 12.9x | -26.8x | |
| $10.8B | 2.5x | 6.8x | |
| $10.2B | 8.3x | 23.8x | |
| $10.2B | 4.4x | 12.2x | |
| $10.1B | 3.1x | 7.6x | |
| $9.8B | 1.5x | 8.3x | |
| $9.5B | n/a | n/a | |
| $9.5B | 1.5x | 12.1x | |
| $9.4B | 3.0x | 12.7x | |
| $9.1B | 917.9x | -15.5x | |
| $6.6B | 11.4x | -37.8x | |
| $6.3B | n/a | -16.7x | |
| $6.3B | 13.4x | 50.6x | |
| $5.7B | 1.9x | 8.6x | |
| $5.7B | 1.7x | 7.6x | |
| $5.6B | 9.8x | 30.0x | |
| $5.6B | 3.9x | 11.5x | |
| $5.5B | n/a | n/a | |
| $5.5B | 10.1x | 40.3x | |
| $5.5B | 1.5x | 9.6x | |
| $5.4B | 5.6x | -43.2x | |
| $5.4B | 6.3x | 22.2x | |
| $5.4B | 1.9x | 5.2x | |
| $5.3B | 6.3x | 28.6x | |
| $5.0B | n/a | n/a | |
| $4.9B | 5.3x | 13.7x | |
| $4.8B | 13.1x | 34.6x | |
| $4.8B | 3.5x | 12.7x | |
| $4.3B | 150.1x | -7.6x | |
| $4.3B | 34.4x | -62.1x | |
| $4.2B | n/a | n/a | |
| $4.1B | 4.5x | 18.3x | |
| $4.0B | 7.9x | 21.1x | |
| $3.9B | 3.0x | 25.3x | |
| $3.8B | 52.3x | -14.0x | |
| $3.8B | 2.6x | 6.6x | |
| $3.8B | 3.5x | 16.5x | |
| $3.8B | 5.0x | 82.4x | |
| $3.8B | 2.2x | 11.0x | |
| $3.8B | 2.4x | 5.6x | |
| $3.5B | 4.3x | n/a | |
| $3.4B | 16.7x | 45.6x | |
| $3.4B | 4.6x | n/a | |
| $3.4B | n/a | n/a | |
| $3.3B | 4.7x | 19.8x | |
| $3.2B | 59.1x | -1529.1x | |
| $3.1B | n/a | -6.5x | |
| $3.0B | 4.4x | 13.1x | |
| $2.9B | 3.4x | 13.6x | |
| $2.6B | 2531.6x | -7.2x | |
| $2.5B | 6.3x | -290.9x | |
| $2.5B | 3.6x | 18.4x | |
| $2.4B | 1.8x | 12.0x | |
| $2.2B | 2.9x | 16.8x | |
| $2.2B | 6.0x | 16.7x | |
| $2.2B | n/a | -8.7x | |
| $2.2B | 9805.6x | n/a | |
| $2.1B | 9.8x | 39.5x | |
| $2.1B | 37.6x | -8.5x | |
| $2.1B | 2.0x | 9.8x | |
| $2.1B | 50.1x | -43.4x | |
| $2.1B | 5.4x | 15.0x | |
| $2.1B | 1.8x | 14.1x | |
| $2.1B | 5.0x | 16.1x | |
| $2.1B | 0.8x | 6.0x | |
| $1.9B | 1.5x | 7.5x |